A+ A A- Skip to main content
26-May-26 SENSEX 76,009.70[ -479.26 ]Adani Ports 1,810.95 [ 8.00 ]Asian Paints 2,646.95 [ -9.45 ]Axis Bank 1,299.45 [ -12.25 ]Bajaj Finance 930.20 [ -11.80 ]Bajaj Finserv 1,800.20 [ -7.00 ]Bharat Electron 420.05 [ -1.70 ]Bharti Airtel 1,846.65 [ -28.40 ]Eternal 250.20 [ 2.45 ]HCL Technologies 1,161.70 [ -4.85 ]HDFC Bank 779.00 [ -7.85 ]Hind. Unilever 2,209.55 [ 12.10 ]ICICI Bank 1,279.15 [ -12.45 ]Infosys 1,167.45 [ -1.20 ]Interglobe Aviat 4,482.80 [ -16.45 ]ITC 301.80 [ -2.20 ]Kotak Mah. Bank 388.70 [ -4.05 ]Larsen & Toubro 4,037.70 [ 4.40 ]M & M 3,107.35 [ -31.50 ]Maruti Suzuki 13,205.05 [ 34.35 ]NTPC 389.45 [ -0.60 ]Power Grid Corpn 292.65 [ -2.60 ]Reliance Industries 1,356.90 [ -9.95 ]SBI 968.60 [ -1.30 ]Sun Pharma.Inds. 1,840.55 [ -0.75 ]Tata Steel 210.45 [ 0.25 ]TCS 2,276.70 [ -31.05 ]Tech Mahindra 1,458.65 [ 23.80 ]Titan Company 4,105.60 [ -51.75 ]Trent 4,239.05 [ -60.05 ]UltraTech Cem. 11,626.25 [ -96.60 ]
IPO Synopsis  
Goldline Pharmaceutical Ltd
Registered Office: [ 103 F-1 Leela Apartment Shilpa , HSG Society Shanidham Narendra , Nagpur - 440015 , Maharashtra , India.
                                  Phone:+91 712 278 6666   Fax:
                                  Email: info@goldlinepharma.in  
                                  Website: www.goldlinepharma.in
Initial public issue of 27,00,000 equity shares of face value of Rs10/- each ("Equity Shares") of Goldline Pharmaceutical Limited ("Issuer" or "The" "company") at an issue price of Rs43 per equity share (including a share premium of Rs33 per equity share) for cash, aggregating to Rs11.61 Crores ("Public Issue") out of which 1,38,000 equity shares of face value of Rs10/- each, at an issue price of Rs43 per equity share for cash, aggregating Rs0.59 Crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. Issue of 25,62,000 equity shares of face value of Rs10/- each, at an issue price of Rs43 per equity share for cash, aggregating up to Rs11.02 Crores is hereinafter referred to as the "Net Issue". The public issue and net issue will constitute 28.13% and 26.69% respectively of the post-issue paid-up equity share capital of the company. Price Band is Rs43 per equity share of face value of Rs10/- each. The floor price is 4.3 times of the face value. Bids can be made for a minimum of Two lot and in multiples of 3,000 equity shares thereafter.
 
Issue Money Payable On
Opens On Closes On Application Allotment
12-May-26 14-May-26 Rs 43.00-0.00 Rs 0.00-0.00
Minimum Application for shares in Nos : 6000   Further Multiples of : 3000
 
  Rs Cr Lead Managers to the Issue
Project Cost 10.06 Cumulative Capital Private Limited
Project Financed through Current Offer 11.61  
Post Issue Equity Share Capital 9.60  
Issue Price Rs.43.00  
 
Projects
Repayment of all or a portion of certain outstanding borrowings availed by its company  General Corporate Purpose 
 
Promoted By
Amol Laxmikant Mujumdar 
Swapan Premprakash Khandelwal 
Asha Swapan Khandelwal 
Listing At
BSE - SME 
Registrar to the Issue
No Data Found.
spacer-img
spacer-img
Site Map  |  Disclaimer  |  Margin Files  | E-Contract Login  |  Fund Transfer
Back Office Login  search
Useful Links :  NSE  |  BSE  |  CDSL  |   Scores   |  Investor Charter  |  EKYC  |  CDSL E-Voting  |  NSDL E-Voting   |  SMART ODR facebook twitter  youtube
Registered Office
B-11, 3rd Floor, Plot-36, Tamarind House, Mudhana Shetty Marg, Hutatma Chowk, Fort, Mumbai - 400 001
Existing customers can send in their Grievances to : investorgrievance@ssbpl.net '/ response@ssbpl.nets
 Attention Investor  |   Terms of Use  |   Privacy Policy  |  Rules & Regulations  |  Investor Protection  |  BSE Investor Complaints
Statutory Charges  |  PMLA / AML Policy  |  CDSL DP Charges   |   Advisory for Investors   |   Bank Details - Shilpa Stock   |   Bank Details - Shikago Trade
AP Details – BSE |    AP Details – NSE   |   KYC Process-Individuals   |    KYC Process - Non Individuals
Online Investor Grievance Redressal  |    Investor Complaints Process Flow  |    Voluntary Freezing/Blocking  |   View Client Collateral Details
KRA Validation Process  |   Re-KYC/Closure  |    Risk Disclosure on Derivative  |   Valid UPI handle Broking   |   Valid UPI Handle DP |  Valid UPI Handle Research   |   Research Analyst Audit Report| Investor Grievance
Validate your Mobile and Email with KRA: CVL KRA  |  KARVY KRA  |  DOTEX KRA  |  CAMS KRA
SEBI Registration Details:

Shilpa Stock Broker Pvt. Ltd.: INZ000201636 | CIN No: U67120MH1999PTC118512 | IN-DP-487-2020 | Research Analyst: INH000000776 | BSE Enlistment No.-5047 Shikago Trade Pvt. Ltd.: INZ000042135

© Copyright 2011 All Rights Reserved.Shilpa Stock Broker Pvt. Ltd.
Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)